Robotic Biopsy Devices Market Size, Share, Trends, Growth Outlook

Robotic Biopsy Devices Market is estimated to increase at a growth rate of 12.8% CAGR over the forecast period from 2024 to 2030.

The global Robotic Biopsy Devices Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (System, Instrument & Accessories), By Application (Lung Biopsy, Brain Biopsy, Prostate Biopsy, Others).

 

An Introduction to Robotic Biopsy Devices Market in 2024

The robotic biopsy devices market is witnessing notable growth in 2024, driven by advancements in robotic-assisted surgical systems, the growing adoption of minimally invasive biopsy techniques, and the increasing demand for precise tissue sampling and diagnostic accuracy in oncology and interventional procedures. Robotic biopsy devices combine robotic platforms with imaging guidance systems and biopsy needles or probes to enable precise, controlled, and navigated tissue sampling from deep-seated or difficult-to-access lesions, offering surgeons and interventional radiologists enhanced procedural accuracy, patient comfort, and diagnostic yield compared to manual biopsy approaches. With innovations in robotic navigation algorithms, image fusion technologies, and needle guidance systems, the market is experiencing rapid expansion and adoption of robotic biopsy devices, facilitating earlier cancer detection, personalized treatment planning, and targeted therapy delivery in oncology practice, improving patient outcomes and survivorship in cancer care.

Robotic Biopsy Devices Market Trend: Advancements in Robotic Biopsy Technology

A prominent trend in the Robotic Biopsy Devices Market is the continuous advancements in robotic biopsy technology. Innovations such as robotic-assisted biopsy systems equipped with advanced imaging modalities, robotic arms with enhanced dexterity and precision, and integration with artificial intelligence for real-time guidance are driving the evolution of biopsy procedures. These technological advancements enable clinicians to perform minimally invasive biopsies with greater accuracy, efficiency, and patient comfort, leading to improved diagnostic outcomes and reduced procedural risks. The trend towards more sophisticated robotic biopsy devices reflects the ongoing quest for precision medicine and personalized patient care in the field of oncology and other medical specialties.

 

Robotic Biopsy Devices Market Driver: Demand for Minimally Invasive Biopsy Procedures

The primary driver of the Robotic Biopsy Devices Market is the increasing demand for minimally invasive biopsy procedures. As healthcare providers strive to minimize patient discomfort, reduce recovery times, and enhance diagnostic accuracy, there is growing preference for minimally invasive approaches to tissue sampling. Robotic biopsy devices offer distinct advantages over traditional biopsy methods, including smaller incisions, precise targeting of lesions, real-time imaging guidance, and reduced risk of complications. The rising prevalence of cancer and other diseases requiring tissue biopsy, coupled with the expanding applications of robotic-assisted techniques, drives the adoption of robotic biopsy devices in clinical practice.

 

Robotic Biopsy Devices Market Opportunity: Expansion of Robotic Biopsy Applications

An opportunity within the Robotic Biopsy Devices Market lies in the expansion of robotic biopsy applications to address a broader range of clinical indications and anatomical sites. While robotic biopsy systems are predominantly used in oncology for the diagnosis and staging of tumors, there is potential to extend their utility to other medical specialties and diagnostic procedures. Healthcare providers can explore opportunities to deploy robotic biopsy devices in areas such as neurology, cardiology, gastroenterology, and pulmonology for tissue sampling, lesion localization, and targeted therapy delivery. By leveraging the versatility and precision of robotic biopsy platforms across multiple clinical domains, healthcare organizations can enhance diagnostic capabilities, optimize treatment planning, and improve patient outcomes.

 

Robotic Biopsy Devices Market Market Segmentation

By Product
System
Instrument & Accessories

By Application
Lung Biopsy
Brain Biopsy
Prostate Biopsy
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Robotic Biopsy Devices Market Companies

Biobot Surgical Pte Ltd
iSYS Medizintechnik GmbH
Mazor Robotics
Medrobotics
Medtech SA
Medtronic
Renishaw plc

 

TABLE OF CONTENTS
1 Introduction to 2024 Robotic Biopsy Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Robotic Biopsy Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Robotic Biopsy Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Robotic Biopsy Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Robotic Biopsy Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Robotic Biopsy Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Robotic Biopsy Devices Industry
4.2 Key Market Trends in Robotic Biopsy Devices Industry
4.3 Potential Opportunities in Robotic Biopsy Devices Industry
4.4 Key Challenges in Robotic Biopsy Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Robotic Biopsy Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Robotic Biopsy Devices Market Outlook by Segments
7.1 Robotic Biopsy Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
System
Instrument & Accessories
By Application
Lung Biopsy
Brain Biopsy
Prostate Biopsy
Others
8 North America Robotic Biopsy Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Robotic Biopsy Devices Markets in 2024
8.2 North America Robotic Biopsy Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Robotic Biopsy Devices Market size Outlook by Segments, 2021-2030
By Product
System
Instrument & Accessories
By Application
Lung Biopsy
Brain Biopsy
Prostate Biopsy
Others
9 Europe Robotic Biopsy Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Robotic Biopsy Devices Markets in 2024
9.2 Europe Robotic Biopsy Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Robotic Biopsy Devices Market Size Outlook by Segments, 2021-2030
By Product
System
Instrument & Accessories
By Application
Lung Biopsy
Brain Biopsy
Prostate Biopsy
Others
10 Asia Pacific Robotic Biopsy Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Robotic Biopsy Devices Markets in 2024
10.2 Asia Pacific Robotic Biopsy Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Robotic Biopsy Devices Market size Outlook by Segments, 2021-2030
By Product
System
Instrument & Accessories
By Application
Lung Biopsy
Brain Biopsy
Prostate Biopsy
Others
11 South America Robotic Biopsy Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Robotic Biopsy Devices Markets in 2024
11.2 South America Robotic Biopsy Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Robotic Biopsy Devices Market size Outlook by Segments, 2021-2030
By Product
System
Instrument & Accessories
By Application
Lung Biopsy
Brain Biopsy
Prostate Biopsy
Others
12 Middle East and Africa Robotic Biopsy Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Robotic Biopsy Devices Markets in 2024
12.2 Middle East and Africa Robotic Biopsy Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Robotic Biopsy Devices Market size Outlook by Segments, 2021-2030
By Product
System
Instrument & Accessories
By Application
Lung Biopsy
Brain Biopsy
Prostate Biopsy
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Biobot Surgical Pte Ltd
iSYS Medizintechnik GmbH
Mazor Robotics
Medrobotics
Medtech SA
Medtronic
Renishaw plc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
System
Instrument & Accessories

By Application
Lung Biopsy
Brain Biopsy
Prostate Biopsy
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)